Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPHA.1-PROTEINASE INHIBITOR HUMAN vs ALPRAZOLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPHA.1-PROTEINASE INHIBITOR HUMAN vs ALPRAZOLAM: Safety Overview

Metric ALPHA.1-PROTEINASE INHIBITOR HUMAN ALPRAZOLAM
Total FAERS Reports 7,110 48,357
Deaths Reported 635 16,072
Death Rate 8.9% 33.2%
Hospitalizations 2,049 15,996
Average Patient Age 61.3 yrs 48.1 yrs
% Female Patients 58.2% 60.4%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Takeda Pharmaceuticals America, Inc. Endo USA, Inc.
Route N/A ORAL
Marketing Status N/A Prescription